NR1H4 and metabolic dysfunction-associated steatotic liver disease: In a porcine model of non-alcoholic fatty liver disease, impaired (bile acid-activated Farnesoid X Receptor) FXR signaling disrupted downstream metabolic and inflammatory pathways (Maj et al., 2023).